• Mithramycin A: Precision Epigenetic Control in Cancer and Ca

  2026-06-29

  Explore how Mithramycin A, a selective anticancer antibiotic, enables advanced DNA-targeted research in oncology and cardiac biology. This article uniquely dissects its dual role as both a c-myc expression inhibitor and a modulator of Sp1/PI3K pathways, with practical insight for translational assay design.

• Cytoskeleton-Dependent Autophagy Under Mechanical Stress

  2026-06-29

  The reference study reveals that cytoskeletal microfilaments are essential for autophagy triggered by mechanical stress in human cells, with microtubules serving an auxiliary role. These findings clarify key mechanotransduction mechanisms and provide a foundation for more targeted experimental approaches in calcium signaling research.

• miR-196a Drives Aggressiveness in Esophageal Adenocarcinoma

  2026-06-28

  This study uncovers how microRNA-196a (miR-196a) enhances the aggressiveness of esophageal adenocarcinoma (EAC) by activating a signaling axis involving c-Myc, TERT, and NFκB. The findings establish miR-196a as both a marker and functional driver of EAC progression, highlighting the centrality of c-Myc in aggressive tumor phenotypes and suggesting new avenues for targeted cancer intervention.

• Regorafenib (BAY 73-4506): Advanced Assay Precision in Tumor

  2026-06-27

  Explore the advanced application of Regorafenib (BAY 73-4506) in precision cancer biology research. This article uncovers unique mechanistic insights and practical protocol strategies, establishing a new benchmark for angiogenesis and tumor progression studies.

• CHIR-99021: Precision GSK-3 Inhibition for Stem Cell Protoco

  2026-06-26

  CHIR-99021 (CT99021) delivers unmatched selectivity for GSK-3α/β, enabling robust control of stem cell pluripotency and differentiation. This article distills experimental workflows, troubleshooting, and recent cross-signaling insights to maximize the compound’s impact in advanced cell engineering.

• 10074-G5: Potent Small-Molecule c-Myc Inhibitor for Cancer R

  2026-06-26

  10074-G5 is a validated small-molecule c-Myc inhibitor that disrupts c-Myc/Max dimerization and demonstrates in vitro and in vivo efficacy in cancer models. With well-characterized IC50 values and robust effects on cell cycle arrest and apoptosis, it is a benchmark tool for dissecting oncogenic transcriptional networks in cancer research.

• CF10 and EdU Synergy Drives Telomere Attrition in CRC Cells

  2026-06-25

  The 2026 study reveals that the fluoropyrimidine polymer CF10, when combined with 5-ethynyl-2′-deoxyuridine (EdU), promotes telomere attrition and mitotic catastrophe in colorectal cancer cells by enhancing EdU incorporation and DNA damage. These findings suggest a unique mechanism for leveraging DNA-directed therapies in telomerase-targeted oncology research.

• Genetic Engineering Boosts T Cell Immunity in Immune-Cold Tu

  2026-06-25

  He et al. introduce a tumor-specific genetic engineering strategy that synergistically enhances T cell infiltration and activity in immune-cold solid tumors. By leveraging a dual-function plasmid vector, the study demonstrates improved efficacy of checkpoint inhibitors and CAR-T therapies with minimal systemic toxicity, offering a promising approach for overcoming resistance in solid tumor immunotherapy.

• Selective Autophagy Regulates IRF3 Stability in Antiviral Im

  2026-06-24

  Wu et al. (2021) uncover how selective autophagy, mediated by CALCOCO2/NDP52 and regulated by PSMD14/POH1, precisely controls IRF3 degradation, balancing type I interferon production and immune suppression. These insights deepen our understanding of innate immune signaling modulation and present new approaches for studying transcription factor regulation in antiviral contexts.

• Enhancing Mammalian Cell Viability Assays with Live-Dead Cel

  2026-06-23

  This article explores how the Live-Dead Cell Staining Kit I (Calcein AM/PI), SKU K2247, addresses core challenges in mammalian cell viability and cytotoxicity assays. Drawing on validated protocols and scenario-driven questions, we demonstrate how this kit delivers reproducible, sensitive results for biomedical researchers, supporting robust data interpretation and workflow reliability.

• AZD6482: Distinct Mechanistic Insights into PI3Kβ Inhibition

  2026-06-23

  Explore how the PI3Kβ inhibitor AZD6482 enables refined experimental design and nuanced pathway exploration. This guide provides advanced, evidence-based perspectives distinct from protocol-centric articles.

• Vorinostat: Epigenetic Modulation and Apoptosis Applications

  2026-06-22

  Vorinostat (suberoylanilide hydroxamic acid) is revolutionizing epigenetic modulation and apoptosis studies in cancer biology by providing precise, reproducible workflows. This article unpacks cutting-edge protocols, troubleshooting strategies, and novel insights from recent RNA Pol II research, empowering researchers to maximize experimental impact.

• miR-196a Drives Esophageal Adenocarcinoma via c-Myc/TERT/NFκ

  2026-06-22

  This study uncovers how microRNA-196a (miR-196a) promotes aggressiveness in esophageal adenocarcinoma by engaging the c-Myc/TERT/NFκB axis. These mechanistic insights highlight new molecular targets for cancer research and underscore the value of c-Myc inhibition in exploring EAC progression.

• APEX2 Drives TERT Expression in Human Embryonic Stem Cells

  2026-06-21

  This study uncovers a novel requirement for the DNA repair enzyme APEX2 in the efficient expression of TERT, the catalytic subunit of telomerase, in human embryonic stem cells. The findings reshape our understanding of telomerase regulation and introduce repetitive DNA element repair as a key control point, with implications for aging and cancer research.

• X-Gal in Sensory Biology: Precision Tools for OSN Assays

  2026-06-20

  Explore how X-Gal, a premier chromogenic substrate, enables advanced blue-white screening and molecular assays in olfactory sensory neuron (OSN) research. This article reveals unique mechanistic insights and practical protocols for leveraging X-Gal in the study of sensory adaptation and gene regulation.

11495 records 1/767 page Next 12345 下5页 Last page